Research Article | Open Access
Naoto Fujita, Fumiko Nagatomo, Shinichiro Murakami, Hiroyo Kondo, Akihiko Ishihara, Hidemi Fujino, "Effects of Hyperbaric Oxygen on Metabolic Capacity of the Skeletal Muscle in Type 2 Diabetic Rats with Obesity", The Scientific World Journal, vol. 2012, Article ID 637978, 9 pages, 2012. https://doi.org/10.1100/2012/637978
Effects of Hyperbaric Oxygen on Metabolic Capacity of the Skeletal Muscle in Type 2 Diabetic Rats with Obesity
We investigated whether hyperbaric oxygen enhances the oxidative metabolic capacity of the skeletal muscle and attenuates adipocyte hypertrophy in type 2 diabetic rats with obesity. Five-week-old male Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) rats were used as diabetic animals and nondiabetic controls, respectively, and assigned to control and hyperbaric oxygen groups. Animals in the hyperbaric oxygen group were exposed to an atmospheric pressure of 1.25 with an oxygen concentration of 36% for 3 h daily. The glucose level at 27 weeks of age was significantly higher in OLETF rats than in LETO rats, but the elevation was inhibited in OLETF rats exposed to hyperbaric oxygen. The slow-to-fast fiber transition in the skeletal muscle was observed in OLETF rats, but the shift was inhibited in OLETF rats exposed to hyperbaric oxygen. Additionally, the oxidative enzyme activity of muscle fibers was increased by hyperbaric oxygen. The adipocyte size was larger in OLETF rats than in LETO rats, but hypertrophied adipocytes were not observed in OLETF rats exposed to hyperbaric oxygen. Hyperbaric oxygen enhances glucose and lipid metabolism in the skeletal muscle, indicating that hyperbaric oxygen can prevent elevation of glucose and adipocyte hypertrophy in diabetic rats with obesity.
Overeating and physical inactivity induce an increased energy intake and result in the enlargement of white adipocytes . It is well known that hypertrophied adipocytes induce obesity and type 2 diabetes . It has been suggested that hypertrophied adipocytes result in the overexpression of tumor necrosis factor-α, causing the insulin resistance that often accompanies obesity . Additionally, hypertrophied adipocytes reduced the expression of adiponectin in obesity, which is associated with the subsequent development of type 2 diabetes . A chronically high glucose level decreases insulin sensitivity in the skeletal muscle and causes insulin resistance . Therefore, skeletal muscles that are affected by insulin resistance cannot adequately dispose glucose because of impaired insulin-stimulated glucose uptake in muscle fibers.
Skeletal muscle, which is considered the principal site of glucose metabolism, plays an important role in glucose regulation. Skeletal muscle fibers are categorized into slow-twitch oxidative (type I), fast-twitch oxidative-glycolytic (type IIA), and fast-twitch glycolytic (type IIB) types based on their contractile and metabolic properties . The metabolic capacity of the skeletal muscle depends on the fiber-type distribution . Substantial differences in glucose metabolism are observed in the rates of glucose uptake among muscle fiber types, and the rate of glucose uptake is greater in skeletal muscle composed presumably of type I and IIA fibers than in those of type IIB fibers . Additionally, the number of glucose transporters is larger in skeletal muscles composed presumably of type I and IIA fibers compared with those of type IIB fibers . Type 2 diabetes leads to disruption of metabolic capacity in skeletal muscle, which is associated with an altered distribution of muscle fiber types. Several studies revealed that skeletal muscles in rats with type 2 diabetes have a lower percentage of type I and IIA fibers and a higher percentage of type IIB fiber than nondiabetic animals [9–12]. Furthermore, a decreased mitochondrial oxidative enzyme activity of muscle fibers has been observed in rats with type 2 diabetes [10, 11, 13, 14]. Therefore, both altered distribution of fiber types and decreased mitochondrial oxidative enzyme activity of fibers in the skeletal muscle could be related to insulin resistance and impaired glucose metabolism.
We previously designed a hyperbaric chamber with an oxygen concentrator and an air compressor and confirmed that hyperbaric oxygen enhances the oxidative metabolic capacity of skeletal muscles and their fibers . The hyperbaric chamber can maintain elevated atmospheric pressure and oxygen concentration; an elevation in atmospheric pressure accompanied by an increase in oxygen concentration enhances the partial pressure of oxygen and increases the blood flow and the concentration of dissolved oxygen in blood plasma. Both elevated atmospheric pressure and oxygen concentration activate mitochondrial oxidative enzyme activity in skeletal muscles and their fibers and cause a shift from fast to slow fibers [16, 17]. The efficacy of hyperbaric oxygen on type 2 diabetes has been reported; hyperbaric oxygen prevents the decrease in the percentage of type I and IIA fibers in skeletal muscle [9, 10, 12] and consequently inhibited an increase in the glucose level . Although the enhanced oxidative metabolic capacity of skeletal muscles induced by hyperbaric oxygen decreases the glucose level in obese and type 2 diabetic subjects, its influence on adipocytes is yet unknown. Obesity-related insulin resistance is associated with the size of adipocytes, and the presence of hypertrophied adipocytes drives the development of insulin resistance . Hypertrophied adipocytes may promote the infiltration of macrophages into adipose tissue, and the cytokines released from macrophages lead to the development of insulin resistance . We hypothesized that hyperbaric oxygen enhances the oxidative metabolic capacity of skeletal muscles, preventing the adipocyte hypertrophy that is associated with insulin resistance. The purpose of the present study was to investigate whether hyperbaric oxygen attenuates adipocyte hypertrophy in type 2 diabetic rats with obesity.
2. Materials and Methods
2.1. Experimental Design
This study was approved by the Institution Animal Care and Use Committee and carried out according to the Kyoto University Animal Experimentation Regulation. All experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (National Research Council, 1996).
Five-week-old male Otsuka Long-Evans Tokushima fatty (OLETF, ) rats were used as type 2 diabetic animals with obesity, and age-matched male Long-Evans Tokushima Otsuka (LETO, ) rats were used as nondiabetic control animals without obesity. All rats were randomly assigned to control hyperbaric oxygen groups. The abbreviations for the groups are as follows: LC, LETO control; LH, LETO exposed to hyperbaric oxygen; OC, OLETF control; and OH, OLETF exposed to hyperbaric oxygen. We designed a hyperbaric chamber for animal experiments that consisted of an oxygen tank with an oxygen concentrator and an air compressor . The chamber was 180 cm long and 70 cm in diameter, and the hyperbaric environment was maintained automatically by a computer-assisted system. The animals in the hyperbaric oxygen group were exposed to an atmospheric pressure of 1.25 with an oxygen concentration of 36% for 3 h daily from 5 to 27 weeks of age. The optimal atmospheric pressure and oxygen concentration were based on the results of a previous study that obtained effective responses with regard to oxidative metabolic capacity in the neuromuscular system . All animals were kept in a controlled environment with fixed 12 : 12 h light : dark cycles and room temperature maintained at °C, excluding exposure to hyperbaric oxygen. Food and water were provided ad libitum for all groups.
2.2. Assessment of Blood Glucose Level
At 27 weeks of age, all animals were anesthetized deeply with an intraperitoneal injection of sodium pentobarbital (50 mg/kg) and blood samples were obtained from the inferior vena cava. The levels of glucose and glycated hemoglobin (HbA1c) were determined in the blood samples.
2.3. Assessment of Skeletal Muscle Fibers and Adipocytes
After blood sampling, the extensor digitorum longus muscle was removed and immediately frozen in acetone cooled by dry ice and stored at −80°C until the analysis. Serial transverse sections of 10 μm thickness were cut on a cryostat (CM-1510S, Leica Microsystems, Mannheim, Germany) from the middle part of the muscle belly in the extensor digitorum longus muscle and mounted on glass slides. The sections were stained for myofibrillar adenosine triphosphatase (ATPase) to categorize the muscle fiber types as type I, IIA, or IIB on the basis of a previous study . For ATPase staining, the sections were preincubated in barbital acetate buffer (pH 4.45) for 5 min at room temperature. Following wash by 0.1 M barbital buffer containing 0.18 M CaCl2 (pH 9.4) for 30 sec, the sections were incubated in 0.1 M barbital buffer containing 0.18 M CaCl2 and 4 mM ATP (pH 9.4) for 45 min at room temperature. The sections were then washed in 1% CaCl2 and in 2% CoCl2 for every 3 min and washed in 0.01 M sodium barbital. Following washing by distilled water, the sections were visualized by 1% ammonium sulfide. The sections were also stained for succinate dehydrogenase (SDH) and cytochrome to determine quantitatively the level of mitochondrial oxidative capacity. For SDH staining, the sections were incubated in 0.05 M phosphate buffer (pH 7.5) containing 0.05% nitro blue tetrazolium and 0.05 M sodium succinate for 45 min at 37°C. For cytochrome staining, the sections were incubated in 0.1 M acetate buffer (pH 5.5) containing 0.002% 3,3′-diaminobenzidine, 0.1% MnCl2, and 0.001% H2O2 for 60 min at 37°C, and then washed in 1% CuSO4 for 5 min. The histochemical images stained by SDH and cytochrome were digitized as gray-scale images and the values of SDH and cytochrome staining intensities were expressed as optical density values. A measuring field was set over the entire muscle cross-section for the determination of muscle fiber-type distribution. At least 100 randomly selected SDH and cytochrome activities of each muscle fiber type were investigated. The sections were measured using the ImageJ software program (NIH, MD, USA). In addition, the epididymal white adipose tissue was removed after the extensor digitorum longus muscle sampling and immediately frozen in acetone cooled by dry ice without fixation. The adipose tissue sample was minced to small pieces and mounted on glass slides. Minced adipose samples were stained with Sudan Red to measure adipocyte diameter and size distribution. The adipocyte diameter was measured by using the ImageJ software program.
2.4. Statistical Analysis
The data were expressed as mean ± SEM. Significant differences between the four groups were analyzed using one-way analysis of variance followed by Tukey HSD post hoc test. Statistical significance was set at .
3.1. Glucose Level
Glucose and HbA1c levels were significantly higher in the OC group than in the LC group (Figure 1). In contrast, glucose and HbA1c levels were significantly lower in the OH group than in the OC group. No significant differences were found between the LC and LH groups.
3.2. Fiber-Type Distribution
The ATPase staining revealed that the extensor digitorum longus muscles were composed of type I, IIA, and IIB fibers (Figure 2). The percentages of type I and IIA fibers were significantly lower in the OC group than in the LC group, and that of IIB fiber was significantly higher in the OC group (Figure 3). However, the percentages of type I and IIA fibers were significantly higher in the OH group than in the OC group, and the percentage of IIB fibers in the OH group was similar to that in the LC group.
3.3. Fiber Mitochondrial Oxidative Capacity
For both the SDH and cytochrome staining, type I and IIA fibers stained darker than type IIB fibers (Figure 4). The mitochondrial oxidative capacity of muscle fibers was increased by hyperbaric oxygen, regardless of the fiber type. The SDH and cytochrome activities of the muscle fibers in the LH group were significantly higher than those in the LC group and the SDH and cytochrome activities of the muscle fibers in the OH group were significantly higher than those in the OC group (Figures 5 and 6). Furthermore, type IIA fibers in the OC group had lower SDH activity than those in the LC group.
3.4. Adipocyte Diameter and Size Distribution
Hypertrophied adipocytes were not observed in the LC group but were abundant in the OC group (Figure 7). The diameter of adipocytes was larger in the OC group than in the LC group (Figure 8(a)), but it was significantly smaller in the OH group than in the OC group. Additionally, hypertrophied adipocytes with diameters larger than 130 μm were not found in the LC group, and the percentage of these adipocytes was lower in the OH group than in the OC group (Figures 8(b)–8(e)).
The present study revealed that hyperbaric oxygen enhances the oxidative metabolic capacity of skeletal muscles and attenuates adipocyte hypertrophy in type 2 diabetic animals with obesity. The fiber-type distribution was altered in the skeletal muscle, and elevation of glucose and adipocyte hypertrophy were observed in type 2 diabetic animals with obesity. However, hyperbaric oxygen activated mitochondrial metabolism and function in muscle fibers and prevented the transition of fibers from slow to fast in diabetic animals, thereby inhibiting the elevation of glucose and adipocyte hypertrophy.
Several studies have shown that the fiber distribution is altered in the skeletal muscle of patients and animals with type 2 diabetes [10, 12, 13, 22]. Additionally, a decreased mitochondrial oxidative enzyme activity was observed in the skeletal muscle of patients and animals with type 2 diabetes [10, 11, 13, 14, 23]. We also found that type 2 diabetic animals with obesity have a lower percentage of type I and IIA fibers and a lower mitochondrial oxidative enzyme activity in type IIA fibers compared with age-matched nondiabetic animals. In the present study, hyperbaric oxygen enhanced mitochondrial oxidative enzyme activity of all fiber types and prevented the transition of fibers from slow to fast in the skeletal muscle of rats with type 2 diabetes. The enhanced oxidative capacity of muscle fibers may be an adaptation to hyperbaric oxygen, which contributes to the increased oxidative metabolic capacity of the skeletal muscle. An increase in both the pressure and concentration of oxygen in blood plasma makes the oxygen available for diffusion into the tissues, generating an increased oxidative capacity in the skeletal oxidative muscles [10, 15]. The increased oxygen availability could have a beneficial impact on skeletal muscle oxidative metabolism. We conclude that hyperbaric oxygen prevents the altered distribution of fiber types and decreased oxidative enzyme activity of fibers in the skeletal muscles of rats with type 2 diabetes and subsequently inhibits the glucose elevation.
Type 2 diabetic rats that were not exposed to hyperbaric oxygen had a higher percentage of hypertrophied adipocytes. In contrast, the percentage decreased in type 2 diabetic rats exposed to hyperbaric oxygen. Fatty acids are transported into mitochondria and broken down to acetyl-CoA through the beta-oxidation of lipids, and the generated acetyl-CoA is used in the tricarboxylic acid (TCA) cycle in aerobic respiration to produce energy and electron carriers. The SDH is an enzyme located in mitochondria and participates in the TCA cycle followed by the electron transport system. Cytochrome c, which is also located in mitochondria, is a component of the electron transport system and has a role in carrying electrons. Both SDH and cytochrome are related to glucose and lipid metabolism in muscle fibers. Enhanced SDH and cytochrome activities in all fiber types in the skeletal muscle were observed in type 2 diabetic rats with hyperbaric oxygen in the present study. Additionally, the rats exposed to hyperbaric oxygen had a high percentage of type I and IIA fibers, which have a high fatty acid oxidation ability , compared with the rats not exposed to hyperbaric oxygen. These results suggest that adipocyte hypertrophy was prevented in type 2 diabetic rats with obesity because hyperbaric oxygen facilitates the turnover of glucose and lipid metabolism in the skeletal muscle.
Hyperbaric oxygen inhibited the growth-related transition of fiber types from slow to fast and the decrease in fiber oxidative enzyme activity in type 2 diabetic rats with obesity, preventing glucose elevation and adipocyte hypertrophy. These results indicate that hyperbaric oxygen enhances the glucose and lipid metabolic capacities of the skeletal muscle, which delays the development of type 2 diabetes and obesity. Increases in the glucose and lipid metabolic capacities of the skeletal muscle were also found after a long-term endurance exercise [25–27]. However, maintaining sufficient exercise training is difficult in obese patients, who often have accompanying physical dysfunctions such as osteoarthritis and myopathy. We therefore propose that hyperbaric oxygen is useful as adjunctive therapy in the treatment of type 2 diabetic patients with obesity.
This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, and Technology.
- T. Sakai, H. Sakaue, T. Nakamura et al., “Skp2 controls adipocyte proliferation during the development of obesity,” Journal of Biological Chemistry, vol. 282, no. 3, pp. 2038–2046, 2007.
- S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006.
- G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993.
- Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999.
- R. A. DeFronzo and E. Ferrannini, “Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease,” Diabetes Care, vol. 14, no. 3, pp. 173–194, 1991.
- A. Lind and D. Kernell, “Myofibrillar ATPase histochemistry of rat skeletal muscles: a 'two-dimensional' quantitative approach,” Journal of Histochemistry and Cytochemistry, vol. 39, no. 5, pp. 589–597, 1991.
- C. Toda, T. Shiuchi, S. Lee et al., “Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues,” Diabetes, vol. 58, no. 12, pp. 2757–2765, 2009.
- L. J. Goodyear, M. F. Hirshman, R. J. Smith, and E. S. Horton, “Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle,” American Journal of Physiology, vol. 261, no. 5, pp. E556–E561, 1991.
- N. Gu, F. Nagatomo, H. Fujino, I. Takeda, K. Tsuda, and A. Ishihara, “Hyperbaric oxygen exposure improves blood glucose level and muscle oxidative capacity in rats with type 2 diabetes,” Diabetes Technology and Therapeutics, vol. 12, no. 2, pp. 125–133, 2010.
- A. Matsumoto, F. Nagatomo, K. Yasuda, K. Tsuda, and A. Ishihara, “Hyperbaric exposure with high oxygen concentration improves altered fiber types in the plantaris muscle of diabetic Goto-Kakizaki rats,” Journal of Physiological Sciences, vol. 57, no. 2, pp. 133–136, 2007.
- F. Nagatomo, H. Fujino, H. Kondo et al., “PGC-1α mRNA level and oxidative capacity of the plantaris muscle in rats with metabolic syndrome, hypertension, and type 2 diabetes,” Acta Histochemica et Cytochemica, vol. 44, no. 2, pp. 73–80, 2011.
- K. Yasuda, T. Adachi, N. Gu et al., “Effects of hyperbaric exposure with high oxygen concentration on glucose and insulin levels and skeletal muscle-fiber properties in diabetic rats,” Muscle and Nerve, vol. 35, no. 3, pp. 337–343, 2007.
- T. Adachi, N. Kikuchi, K. Yasuda et al., “Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-γ coactivator-1α of fibres in the soleus muscle of Zucker diabetic fatty rats,” Experimental Physiology, vol. 92, no. 2, pp. 449–455, 2007.
- J. He, S. Watkins, and D. E. Kelley, “Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity,” Diabetes, vol. 50, no. 4, pp. 817–823, 2001.
- A. Ishihara, F. Kawano, T. Okiura, F. Morimatsu, and Y. Ohira, “Hyperbaric exposure with high oxygen concentration enhances oxidative capacity of neuromuscular units,” Neuroscience Research, vol. 52, no. 2, pp. 146–152, 2005.
- B. Kurt, Y. Kurt, Y. Karslioǧlu et al., “Effects of hyperbaric oxygen on energy production and xanthine oxidase levels in striated muscle tissue of healthy rats,” Journal of Clinical Neuroscience, vol. 15, no. 4, pp. 445–450, 2008.
- A. Matsumoto, T. Okiura, F. Morimatsu, Y. Ohira, and A. Ishihara, “Effects of hyperbaric exposure with high oxygen concentration on the physical activity of developing rats,” Developmental Neuroscience, vol. 29, no. 6, pp. 452–459, 2007.
- K. Yasuda, N. Aoki, T. Adachi et al., “Hyperbaric exposure with high oxygen concentration inhibits growth-associated increase in the glucose level of diabetic Goto-Kakizaki rats,” Diabetes, Obesity and Metabolism, vol. 8, no. 6, pp. 714–715, 2006.
- T. B. Koenen, C. J. Tack, J. M. Kroese et al., “Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4453–4457, 2009.
- G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli et al., “Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone,” Diabetes, vol. 54, no. 8, pp. 2305–2313, 2005.
- K. Punkt, A. Naupert, and G. Asmussen, “Differentiation of rat skeletal muscle fibres during development and ageing,” Acta Histochemica, vol. 106, no. 2, pp. 145–154, 2004.
- B. Nyholm, Z. Qu, A. Kaal et al., “Evidence of an increased number of type IIb muscle fibers in insulin- resistant first-degree relatives of patients with NIDDM,” Diabetes, vol. 46, no. 11, pp. 1822–1828, 1997.
- A. E. Civitarese, P. S. MacLean, S. Carling et al., “Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL,” Cell Metabolism, vol. 11, no. 5, pp. 412–426, 2010.
- K. M. Baldwin, R. E. Herrick, and S. A. McCue, “Substrate oxidation capacity in rodent skeletal muscle: effects of exposure to zero gravity,” Journal of Applied Physiology, vol. 75, no. 6, pp. 2466–2470, 1993.
- B. T. Bikman, T. L. Woodlief, R. C. Noland et al., “High-fat diet induces ikk and reduces insulin sensitivity in rats with low running capacity,” International Journal of Sports Medicine, vol. 30, no. 9, pp. 631–635, 2009.
- R. C. Noland, J. P. Thyfault, S. T. Henes et al., “Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance,” American Journal of Physiology, vol. 293, no. 1, pp. E31–E41, 2007.
- E. R. Ropelle, J. R. Pauli, P. O. Prada et al., “Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation,” Journal of Physiology, vol. 577, no. 3, pp. 997–1007, 2006.
Copyright © 2012 Naoto Fujita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.